↓ Skip to main content

Dove Medical Press

Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells

Overview of attention for article published in Drug Design, Development and Therapy, June 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Readers on

mendeley
19 Mendeley
Title
Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells
Published in
Drug Design, Development and Therapy, June 2013
DOI 10.2147/dddt.s45890
Pubmed ID
Authors

Hsin-chung Lee, Qing-Dong Ling, Wan-Chun Yu, Chunh-Ming Hung, Ta-Chun Kao, Yi-Wei Huang, Akon Higuchi

Abstract

We evaluated the higher levels of carcinoembryonic antigen (CEA) secreted by the LoVo human colon carcinoma cells in a medium containing anticancer drugs. Drug-resistant LoVo cells were analyzed by subcutaneously xenotransplanting them into mice. The aim of this study was to evaluate whether the drug-resistant cells isolated in this study were cancer-initiating cells, known also as cancer stem cells (CSCs).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 5%
Unknown 18 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 21%
Student > Ph. D. Student 3 16%
Other 2 11%
Student > Bachelor 2 11%
Student > Master 2 11%
Other 3 16%
Unknown 3 16%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 26%
Medicine and Dentistry 4 21%
Agricultural and Biological Sciences 2 11%
Unspecified 1 5%
Chemistry 1 5%
Other 1 5%
Unknown 5 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2013.
All research outputs
#22,759,802
of 25,374,917 outputs
Outputs from Drug Design, Development and Therapy
#1,754
of 2,268 outputs
Outputs of similar age
#181,529
of 206,481 outputs
Outputs of similar age from Drug Design, Development and Therapy
#19
of 23 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,481 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.